OBJECTIVE: To use quantitative magnetic resonance imaging (MRI) to test whether mediobasal hypothalamic (MBH) gliosis is associated with obesity and insulin resistance in humans. METHODS: Sixty-seven participants underwent a fasting blood draw and MRI. Cases with radiologic evidence of MBH gliosis (N = 22) were identified as the upper tertile of left MBH T2 relaxation time and were compared to controls (N = 23) from the lowest tertile. In a separate postmortem study, brain slices (N = 10) through the MBH were imaged by MRI and stained for glial fibrillary acidic protein (GFAP). RESULTS: In all participants, longer T2 relaxation time in the left MBH was associated with higher BMI (P = 0.01). Compared with controls, cases had longer T2 relaxation times in the right MBH (P < 0.05), as well as higher BMI (P < 0.05), fasting insulin concentrations (P < 0.01), and HOMA-IR values (P < 0.01), adjusted for sex and age. Elevations in insulin and HOMA-IR were also independent of BMI. In the postmortem study, GFAP staining intensity was positively associated with MBH T2 relaxation time (P < 0.05), validating an MRI-based method for the detection of MBH gliosis in humans. CONCLUSIONS: These findings link hypothalamic gliosis to insulin resistance in humans and suggest that the link is independent of the level of adiposity.
OBJECTIVE: To use quantitative magnetic resonance imaging (MRI) to test whether mediobasal hypothalamic (MBH) gliosis is associated with obesity and insulin resistance in humans. METHODS: Sixty-seven participants underwent a fasting blood draw and MRI. Cases with radiologic evidence of MBH gliosis (N = 22) were identified as the upper tertile of left MBH T2 relaxation time and were compared to controls (N = 23) from the lowest tertile. In a separate postmortem study, brain slices (N = 10) through the MBH were imaged by MRI and stained for glial fibrillary acidic protein (GFAP). RESULTS: In all participants, longer T2 relaxation time in the left MBH was associated with higher BMI (P = 0.01). Compared with controls, cases had longer T2 relaxation times in the right MBH (P < 0.05), as well as higher BMI (P < 0.05), fasting insulin concentrations (P < 0.01), and HOMA-IR values (P < 0.01), adjusted for sex and age. Elevations in insulin and HOMA-IR were also independent of BMI. In the postmortem study, GFAP staining intensity was positively associated with MBH T2 relaxation time (P < 0.05), validating an MRI-based method for the detection of MBH gliosis in humans. CONCLUSIONS: These findings link hypothalamic gliosis to insulin resistance in humans and suggest that the link is independent of the level of adiposity.
Authors: Donghoon Lee; Joshua P Thaler; Kathryn E Berkseth; Susan J Melhorn; Michael W Schwartz; Ellen A Schur Journal: Am J Physiol Endocrinol Metab Date: 2013-04-02 Impact factor: 4.310
Authors: Chun-Xia Yi; Omar Al-Massadi; Elizabeth Donelan; Maarit Lehti; Jon Weber; Chandler Ress; Chitrang Trivedi; Timo D Müller; Stephen C Woods; Susanna M Hofmann Journal: Physiol Behav Date: 2012-03-29
Authors: Marciane Milanski; Giovanna Degasperi; Andressa Coope; Joseane Morari; Raphael Denis; Dennys E Cintra; Daniela M L Tsukumo; Gabriel Anhe; Maria E Amaral; Hilton K Takahashi; Rui Curi; Helena C Oliveira; José B C Carvalheira; Silvana Bordin; Mário J Saad; Lício A Velloso Journal: J Neurosci Date: 2009-01-14 Impact factor: 6.167
Authors: Jonathan P German; Brent E Wisse; Joshua P Thaler; Shinsuke Oh-I; David A Sarruf; Kayoko Ogimoto; Karl J Kaiyala; Jonathan D Fischer; Miles E Matsen; Gerald J Taborsky; Michael W Schwartz; Gregory J Morton Journal: Diabetes Date: 2010-04-27 Impact factor: 9.461
Authors: G D Jackson; S R Williams; R O Weller; N van Bruggen; N E Preece; S C Williams; W H Butler; J S Duncan Journal: Epilepsy Res Date: 1994-05 Impact factor: 3.045
Authors: Kathryn E Berkseth; Stephan J Guyenet; Susan J Melhorn; Donghoon Lee; Joshua P Thaler; Ellen A Schur; Michael W Schwartz Journal: Endocrinology Date: 2014-06-10 Impact factor: 4.736
Authors: Kelly A Posey; Deborah J Clegg; Richard L Printz; Jaeman Byun; Gregory J Morton; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Denis G Baskin; Jay W Heinecke; Stephen C Woods; Michael W Schwartz; Kevin D Niswender Journal: Am J Physiol Endocrinol Metab Date: 2008-12-30 Impact factor: 4.310
Authors: Leticia E Sewaybricker; Ellen A Schur; Susan J Melhorn; Brunno M Campos; Mary K Askren; Guilherme A S Nogueira; Mariana P Zambon; Maria Angela R G M Antonio; Fernando Cendes; Licio A Velloso; Gil Guerra-Junior Journal: Pediatr Obes Date: 2018-12-10 Impact factor: 4.000
Authors: Mohammed K Hankir; Michael Rullmann; Florian Seyfried; Sven Preusser; Sindy Poppitz; Stefanie Heba; Konstantinos Gousias; Jana Hoyer; Tatjana Schütz; Arne Dietrich; Karsten Müller; Burkhard Pleger Journal: JCI Insight Date: 2019-10-03
Authors: Martin Valdearcos; John D Douglass; Megan M Robblee; Mauricio D Dorfman; Daniel R Stifler; Mariko L Bennett; Irene Gerritse; Rachael Fasnacht; Ben A Barres; Joshua P Thaler; Suneil K Koliwad Journal: Cell Metab Date: 2017-07-05 Impact factor: 27.287
Authors: Michael W Schwartz; Randy J Seeley; Lori M Zeltser; Adam Drewnowski; Eric Ravussin; Leanne M Redman; Rudolph L Leibel Journal: Endocr Rev Date: 2017-08-01 Impact factor: 19.871